Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Industrial Microbiology & Biotechnology|January 15, 2008
Spatial expression of a mercury-inducible green fluorescent protein within a nanoporous latex-based biosensor coatingJanet L Schottel, Paul M Orwin, C Ron Anderson, et al.Journal of Pediatric Surgery|May 13, 2009
A multiinstitutional review of central venous line complications: retained intravascular fragmentsKris Milbrandt, Paul Beaudry, Ron Anderson, et al.The Spine Journal : Official Journal of the North American Spine Society|February 3, 2025
Expandable interbody cages for lumbar spinal fusion: a systematic reviewDaniel Orr, Ron Anderson, Anna Jensen, et al.Neurocase|July 11, 2017
Hyper-brain connectivity in binge drinking college students: a diffusion tensor imaging studyKarl Kashfi, Kareem Al-Khalil, Jiancheng Hou, et al.Plos One|February 3, 2022
Integrating quantitative and qualitative approaches to assess wintertime illness-related absenteeism and its direct and indirect costs among the private sector in UlaanbaatarMandukhai Ganbat, Nasantogtokh Erdenebileg, Chuluunbileg Batbold, et al.British Journal of Haematology|July 22, 2006
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro studyStefan Kuhle, Alice Lau, Laszlo Bajzar, et al.Thrombosis and Haemostasis|May 15, 2002
Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with AsparaginaseChristoph Male, Peter Chait, Jeffrey S Ginsberg, et al.Thrombosis and Haemostasis|July 31, 2003
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA studyLesley Mitchell, Maureen Andrew, Kim Hanna, et al.Cancer|January 9, 2003
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) StudyLesley G Mitchell, Maureen Andrew, Kim Hanna, et al.Pageof 1